Yuyu Pharma Capital Reinvestment Ratio

Latest as of September 2025: 1.75x

Yuyu Pharma capital reinvestment ratio. Yuyu Pharma (000220) has a Capital Reinvestment Ratio of 1.75x as of September 2025, meaning it reinvests 2% of its operating cash flow (₩836.62 Million) in capital expenditures (₩1.46 Billion). See Yuyu Pharma free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.75x
Capex / Operating Cash Flow

Operating Cash Flow

₩836.62 Million
KRW

Capital Expenditures

₩1.46 Billion
KRW

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Yuyu Pharma (2011–2024)

Capital reinvestment ratio of Yuyu Pharma from 2011 to 2024. This chart tracks Yuyu Pharma's Capital Reinvestment Ratio across 10 annual periods. See financial agility of Yuyu Pharma to measure the company's free cash flow as a share of total liabilities.

Yuyu Pharma Capital Reinvestment Ratio by Year (2011–2024)

Yuyu Pharma capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see Yuyu Pharma cash conversion from operations.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.29x ₩24.95 Billion ₩7.30 Billion ▼ -97.6%
2023 12.13x ₩420.86 Million ₩5.11 Billion ▲ +800.7%
2021 1.35x ₩4.51 Billion ₩6.07 Billion ▲ +120.5%
2019 0.61x ₩13.19 Billion ₩8.06 Billion ▼ -61.8%
2018 1.60x ₩6.11 Billion ₩9.76 Billion ▼ -82.7%
2017 9.25x ₩561.35 Million ₩5.19 Billion ▲ +3819.4%
2016 0.24x ₩9.82 Billion ₩2.32 Billion ▼ -20.4%
2014 0.30x ₩1.36 Billion ₩404.37 Million ▲ +139.8%
2012 0.12x ₩6.51 Billion ₩805.15 Million ▲ +102.1%
2011 0.06x ₩6.67 Billion ₩408.49 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow